Author Correction: Environment-responsive nanophores for therapy and treatment monitoring via molecular MRI quenching (Nature Communications, (2014), 5, 1, (3384), 10.1038/ncomms4384);Environment-responsive nanophores for therapy and treatment monitoring via molecular MRI quenching

Nature Communications

Volumn 5, Issue , 2014, Pages

  Kaittanis, Charalambos ^a   Shaffer, Travis M ^a,b   Ogirala, Anuja ^a   Santra, Santimukul ^c   Perez, J Manuel ^d   Chiosis, Gabriela ^a   Li, Yueming ^a   Josephson, Lee ^e   Grimm, Jan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c PITTSBURG STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CENTRAL FLORIDA   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERUMOXYTOL; NANOPARTICLE; NANOPHORE; UNCLASSIFIED DRUG; MAGNETITE;

DRUG; MOLECULAR ANALYSIS; MONITORING; NUCLEAR MAGNETIC RESONANCE; PARTICULATE MATTER; PH; TOXICITY;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL MODIFICATION; CHEMOTHERAPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MONITORING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PH; PROTON NUCLEAR MAGNETIC RESONANCE; RELAXATION TIME; STATIC ELECTRICITY; CHEMISTRY; PROCEDURES;

FERROSOFERRIC OXIDE; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE IMAGING; NANOPARTICLES;

EID: 84895833422     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-019-09887-3     Document Type: Erratum

References (43)

1. Duncan, R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. 2, 347-360 (2003). (Pubitemid 37361705)
2. Duncan, R. Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer 6, 688-701 (2006). (Pubitemid 44286001)
3. Huang, P. S. & Oliff, A. Drug-targeting strategies in cancer therapy. Curr. Opin. Genet. Dev. 11, 104-110 (2001). (Pubitemid 32119286)
4. Moses, M. A., Brem, H. & Langer, R. Advancing the field of drug delivery: taking aim at cancer. Cancer Cell 4, 337-341 (2003). (Pubitemid 37491094)
5. Qian, Z. M., Li, H., Sun, H. & Ho, K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 54, 561-587 (2002). (Pubitemid 35351196)
6. Kularatne, S. A., Wang, K., Santhapuram, H. K. & Low, P. S. Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand. Mol. Pharm. 6, 780-789 (2009).
7. Low, P. S., Henne, W. A. & Doorneweerd, D. D. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc. Chem. Res. 41, 120-129 (2008).
8. Gaind, V., Kularatne, S., Low, P. S. & Webb, K. J. Deep-tissue imaging of intramolecular fluorescence resonance energy-transfer parameters. Opt. Lett. 35, 1314-1316 (2010).
9. Lu, Z. R. Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man. Adv. Drug Deliv. Rev. 62, 246-257 (2010).
10. Theeraladanon, C. et al. Rational approach to the synthesis, evaluation, and (68)ga labeling of a novel 4-anilinoquinoline epidermal growth factor receptor inhibitor as a new imaging agent that selectively targets the epidermal growth factor receptor tyrosine kinase. Cancer Biother. Radiopharm. 25, 479-485 (2010).
11. Santra, S., Kaittanis, C., Santiesteban, O. J. & Perez, J. M. Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy. J. Am. Chem. Soc. 133, 16680-16688 (2011).
12. Hamburg, M. A. Science and regulation. FDA's approach to regulation of products of nanotechnology. Science 336, 299-300 (2012).
13. Josephson, L. & Rudin, M. Barriers to clinical translation with diagnostic drugs. J. Nucl. Med. 54, 329-332 (2013).
14. Zhang, Y., Chan, H. F. & Leong, K. W. Advanced materials and processing for drug delivery: The past and the future. Adv. Drug Deliv. Rev. 65, 104-120 (2013).
15. Blanco, E. et al. Molecular-targeted nanotherapies in cancer: enabling treatment specificity. Mol. Oncol. 5, 492-503 (2011).
16. Prakash, S., Malhotra, M., Shao, W., Tomaro-Duchesneau, C. & Abbasi, S. Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy. Adv. Drug Deliv. Rev. 63, 1340-1351 (2011).
17. Schroeder, A. et al. Treating metastatic cancer with nanotechnology. Nat. Rev. Cancer. 12, 39-50 (2012).
18. O'Brien, M. E. et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann. Oncol. 15, 440-449 (2004). (Pubitemid 38444547)
19. Ringden, O. et al. Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J. Antimicrob. Chemother. 28(Suppl B): 73-82 (1991).
20. McCarthy, J. R., Perez, J. M., Bruckner, C. & Weissleder, R. Polymeric nanoparticle preparation that eradicates tumours. Nano Lett. 5, 2552-2556 (2005). (Pubitemid 43088911)
21. Santra, S., Kaittanis, C. & Perez, J. M. Cytochrome C encapsulating theranostic nanoparticles: a novel bifunctional system for targeted delivery of therapeutic membrane-impermeable proteins to tumours and imaging of cancer therapy. Mol. Pharm. 7, 1209-1222 (2010).
22. Santra, S., Kaittanis, C. & Perez, J. M. Aliphatic hyperbranched polyester: a new building block in the construction of multifunctional nanoparticles and nanocomposites. Langmuir 26, 5364-5373 (2010).
23. Hrkach, J. et al. Preclinical development and clinical translation of a PSMA-Targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci. Transl. Med. 4, 128ra139 (2012).
24. Grimm, J., Perez, J. M., Josephson, L. & Weissleder, R. Novel nanosensors for rapid analysis of telomerase activity. Cancer Res. 64, 639-643 (2004). (Pubitemid 38120904)
25. Kaittanis, C., Boukhriss, H., Santra, S., Naser, S. A. & Perez, J. M. Rapid and sensitive detection of an intracellular pathogen in human peripheral leukocytes with hybridizing magnetic relaxation nanosensors. PLoS One 7, e35326 (2012).
26. Kaittanis, C., Naser, S. A. & Perez, J. M. One-step, nanoparticle-mediated bacterial detection with magnetic relaxation. Nano Lett. 7, 380-383 (2007). (Pubitemid 46383601)
27. Kaittanis, C., Nath, S. & Perez, J. M. Rapid nanoparticle-mediated monitoring of bacterial metabolic activity and assessment of antimicrobial susceptibility in blood with magnetic relaxation. PLoS One 3, e3253 (2008).
28. Kaittanis, C., Santra, S. & Perez, J. M. Emerging nanotechnology-based strategies for the identification of microbial pathogenesis. Adv. Drug Deliv. Rev. 62, 408-423 (2010).
29. Perez, J. M., Grimm, J., Josephson, L. & Weissleder, R. Integrated nanosensors to determine levels and functional activity of human telomerase. Neoplasia 10, 1066-1072 (2008).
30. Perez, J. M., Josephson, L., O'Loughlin, T., Hogemann, D. & Weissleder, R. Magnetic relaxation switches capable of sensing molecular interactions. Nat. Biotechnol. 20, 816-820 (2002). (Pubitemid 34836759)
31. Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033 (2009).
32. Carver, B. S. et al. Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell 19, 575-586 (2011).
33. Haun, J. B. et al. Micro-NMR for rapid molecular analysis of human tumour samples. Sci. Transl. Med. 3, 71ra16 (2011).
34. Issadore, D. et al. Miniature magnetic resonance system for point-of-care diagnostics. Lab. Chip. 11, 2282-2287 (2011).
35. Caravan, P. in Molecular and Cellular MR Imaging (eds Modo, M. M. J. & Bulte, J. W. M.) 13-36 (CRC Press, 2007).
36. Ahrens, E. T. & Bulte, J. W. Tracking immune cells in vivo using magnetic resonance imaging. Nat. Rev. Immunol. 13, 755-763 (2013).
37. Koh, I., Hong, R., Weissleder, R. & Josephson, L. Nanoparticle-target interactions parallel antibody-protein interactions. Anal. Chem. 81, 3618-3622 (2009).
38. Kaittanis, C., Santra, S., Santiesteban, O. J., Henderson, T. J. & Perez, J. M. The assembly state between magnetic nanosensors and their targets orchestrates their magnetic relaxation response. J. Am. Chem. Soc. 133, 3668-3676 (2011).
39. Taktak, S., Sosnovik, D., Cima, M. J., Weissleder, R. & Josephson, L. Multiparameter magnetic relaxation switch assays. Anal. Chem. 79, 8863-8869 (2007). (Pubitemid 350231692)
40. Aslan, K., Lakowicz, J. R. & Geddes, C. D. Nanogold-plasmon- resonance-based glucose sensing. Anal. Biochem. 330, 145-155 (2004). (Pubitemid 38746986)
41. Yoshizumi, A., Kanayama, N., Maehara, Y., Ide, M. & Kitano, H. Self-assembled monolayer of sugar-carrying polymer chain: Sugar balls from 2-methacryloyloxyethyl D-glucopyranoside. Langmuir. 15, 482-488 (1999).
42. Santra, S., Kaittanis, C., Grimm, J. & Perez, J. M. Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging. Small 5, 1862-1868 (2009).
43. Nath, S., Kaittanis, C., Ramachandran, V., Dalal, N. & Perez, J. M. Synthesis, magnetic characterization and sensing applications of novel dextran-coated iron oxide nanorods. Chem. Mater. 21, 1761-1767 (2009).